| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.004 | 1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |